相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines
Christopher J. H. Davitt et al.
MUCOSAL IMMUNOLOGY (2019)
Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant
Jan Holmgren et al.
VACCINE (2018)
Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization
Louise Sjokvist Ottsjo et al.
IMMUNOLOGY (2017)
Gastric expression of IL-17A and IFNγ in Helicobacter pylori infected individuals is related to symptoms
Jenni Adamsson et al.
CYTOKINE (2017)
A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens
Christopher J. H. Davitt et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae
Michael Lebens et al.
VACCINE (2016)
Vaccine against Helicobacter pylori: Inevitable approach
Amin Talebi Bezmin Abadi
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Defining the Roles of IFN-γ and IL-17A in Inflammation and Protection against Helicobacter pylori Infection
Louise Sjokvist Ottsjo et al.
PLOS ONE (2015)
Th1 and Th17 Responses to Helicobacter pylori in Bangladeshi Infants, Children and Adults
Taufiqur R. Bhuiyan et al.
PLOS ONE (2014)
Helicobacter pylori vaccination: Is there a path to protection?
Florian Anderl et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Immune responses to Helicobacter pylori infection
Mati Moyat et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
A Double Mutant Heat-Labile Toxin from Escherichia coli, LT(R192G/L211A), Is an Effective Mucosal Adjuvant for Vaccination against Helicobacter pylori Infection
Louise Sjokvist Ottsjo et al.
INFECTION AND IMMUNITY (2013)
Plasticity of TH17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses
Keiji Hirota et al.
NATURE IMMUNOLOGY (2013)
Th17 Cells Upregulate Polymeric Ig Receptor and Intestinal IgA and Contribute to Intestinal Homeostasis
Anthony T. Cao et al.
JOURNAL OF IMMUNOLOGY (2012)
Enhancement of Helicobacter pylori outer inflammatory protein DNA vaccine efficacy by co-delivery of interleukin-2 and B subunit heat-labile toxin gene encoded plasmids
Jiansen Chen et al.
MICROBIOLOGY AND IMMUNOLOGY (2012)
Interleukin-17 Contributes to Generation of Th1 Immunity and Neutrophil Recruitment during Chlamydia muridarum Genital Tract Infection but Is Not Required for Macrophage Influx or Normal Resolution of Infection
Amy M. Scurlock et al.
INFECTION AND IMMUNITY (2011)
A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori
Carl-Fredrik Flach et al.
VACCINE (2011)
Excessive Interleukin-1 Signaling Determines the Development of Th1 and Th17 Responses in Chronic Inflammation
Leo A. B. Joosten
ARTHRITIS AND RHEUMATISM (2010)
Sublingual Immunization Protects against Helicobacter pylori Infection and Induces T and B Cell Responses in the Stomach
Sukanya Raghavan et al.
INFECTION AND IMMUNITY (2010)
Immune Responses to Helicobacter pylori Infection in Bangladeshi Children during Their First Two Years of Life and the Association between Maternal Antibodies and Onset of Infection
Taufiqur Rahman Bhuiyan et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
IL-22 defines a novel immune pathway of antifungal resistance
A. De Luca et al.
MUCOSAL IMMUNOLOGY (2010)
Enhanced M1 Macrophage Polarization in Human Helicobacter pylori-Associated Atrophic Gastritis and in Vaccinated Mice
Marianne Quiding-Jarbrink et al.
PLOS ONE (2010)
Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax
Sandip K. Datta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Mucosal Adjuvant Effect of α-Galactosylceramide for Induction of Protective Immunity to Sexually Transmitted Viral Infection
Madelene Lindqvist et al.
JOURNAL OF IMMUNOLOGY (2009)
Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens
Amy N. Courtney et al.
VACCINE (2009)
alpha-Galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial
Andrea M. Woltman et al.
ANTIVIRAL THERAPY (2009)
Harnessing invariant NKT cells in vaccination strategies
Vincenzo Cerundolo et al.
NATURE REVIEWS IMMUNOLOGY (2009)
α-galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor
SY Ko et al.
JOURNAL OF IMMUNOLOGY (2005)
Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection
AA Akhiani et al.
JOURNAL OF IMMUNOLOGY (2004)
Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells
AA Akhiani et al.
JOURNAL OF IMMUNOLOGY (2002)
Protection against experimental Helicobacter pylori infection after immunization with inactivated H-pylori whole-cell vaccines
S Raghavan et al.
INFECTION AND IMMUNITY (2002)
Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis
S Raghavan et al.
INFECTION AND IMMUNITY (2002)
分享论文
